Yes, I did notice the new panel of experts. I must admit, I couldn't help thinking that OPT sure knows how to spend my money!
Interesting—where do you place the probabilities of success for the Phase 3 trials, specifically for COAST (Aflibercept/Eylea) and ShORe (Ranibizumab/Lucentis)? Then gaining approval by FDA?
Here’s what my OptheaGPT is saying (if anyone has any documents to link, I can add them to my OptheaGPT knowledge).
Yes, I did notice the new panel of experts. I must admit, I...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.035(3.72%) |
Mkt cap ! $1.200B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | $1.00 | 94.5¢ | $2.974M | 3.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2874 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/01/2025 (20 minute delay) ? |
| OPT (ASX) Chart |